Open AccessCeny leków – teoria i praktyka
Author(s) -
Aleksandra Zawada,
Anna Korecka-Polak,
Bartosz Kobuszewski
Publication year - 2019
Publication title -
zeszyty naukowe ochrony zdrowia, zdrowie publiczne i zarządzanie/zeszyty naukowe ochrony zdrowia, zdrowie publiczne i zarządzanie
Language(s) - English
Resource type - Journals
eISSN - 2084-2627
pISSN - 1731-7398
DOI - 10.4467/20842627oz.19.021.12183
Subject(s) - reimbursement , payment , christian ministry , commission , european commission , public economics , business , actuarial science , public administration , accounting , economics , political science , law , finance , health care , european union , economic policy
Drug prices – theory and practice Prices of reimbursed drugs in Poland are regulated by law and closely monitored, which has been specified in reimbursement act. It contains, among others, rules regarding drug pricing, payments, limit groups and it also defines mechanisms of access to reimbursed medicines. In addition to aforementioned reimbursement act, the important role in drug policy in Poland plays the Economic Commission operating at the Ministry of Health and the European Commission. Current rules of drug financing from public funds in Poland are precisely detailed, and therefore may be incomprehensible to a large part of society. The aim of this publication is to present theoretical aspects of drug reimbursement and associated with this most common problems in practice.